European Confederation of Pharmaceutical Entrepreneurs has 32 disclosed EU lobbying meetings from 2024-09-24 to 2026-05-06: 11 with the European Commission and 21 with Members of the European Parliament. Source: EU Transparency Register no. 87600691525-93, Commission disclosures and MEP declarations. Methodology
European Confederation of Pharmaceutical Entrepreneurs
EU lobbying footprint — who they meet, and on what.
- Register no.
- 87600691525-93 ↗
- Disclosed meetings
- 32 (11 Commission · 21 MEP)
- Period
- 2024-09-24 → 2026-05-06
Declared fields of interest: Business and industry · Competition · Consumers · Digital economy and society · Economy, finance and the euro · Food safety · Institutional affairs · Public health · Research and innovation · Single market · Trade
Lobbying profile
as declared 2026-05-13- Category
- Trade and business associations
- Legal status
- AISBL
- Declared lobbying cost
- €800,000
- Lobbying FTEs
- 4.2
- Members
- 2
At a glance
- Technology3
- Health3
- Maya Matthews4
- Jana Dabbelt2
- Katri Teedumäe1
- Ann-Sofie Ronnlund1
- Olivér Várhelyi1
Disclosed meetings
Newest first. EC = European Commission, EP = Member of the European Parliament.
- 2026-05-06ECMaya Matthews · Head of UnitExchange of views on reaching out to Small and Medium Enterprises (SMEs) under the Health Technology Assessment (HTA) Regulationsource ↗
- Health Policysource ↗
- Biotech Actsource ↗
- Rare diseasessource ↗
- Strengthening EU Action on Rare Diseases and Life Sciences Competitivenesssource ↗
- 2026-04-16ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- HTAsource ↗
- Exchange of Views with the European Confederation of Pharmaceutical Entrepreneurs on the UCPM and Health Preparednesssource ↗
- 2026-02-11ECMaya Matthews · Head of UnitExchange of views on operations under the HTA Regulation with a focus on joint clinical assessments (JCAs)source ↗
- 2025-10-22ECMaya Matthews · Head of UnitExchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation.source ↗
- 2025-10-16ECKatri Teedumäe · Cabinet of Commissioner Olivér VárhelyiSituation of medium sized innovative pharma sectorsource ↗
- 2025-10-02ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiAll pressing portfolio topicssource ↗
- production of critical medicines in the EUsource ↗
- Critical Medicines Actsource ↗
- EU Health Care Policiessource ↗
- APA Training on CBRN Threatssource ↗
- Health policysource ↗
- 2025-07-03ECAnn-Sofie Ronnlund · Cabinet of Commissioner Ekaterina ZaharievaLife sciencessource ↗
- 2025-06-17ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiEU biotech policysource ↗
- Critical Medicines Actsource ↗
- Introductory Meetingsource ↗
- Health securitysource ↗
- 2025-04-29ECLaszlo Andrejko · Cabinet of Commissioner Olivér VárhelyiBiotechsource ↗
- Pharmaceutical Industry in the EUsource ↗
- 2025-03-27ECMaya Matthews · Head of UnitEU HTA regulationsource ↗
- Health policysource ↗
- Healthsource ↗
- Introductory meetingsource ↗
- 2024-11-21ECMarc Lemaitre · Director-GeneralEUCOPE’s priorities and the perspective of the smaller innovative pharmaceutical industrysource ↗
- European health policysource ↗
- Life sciences industrysource ↗
- Generel exchange (staff level)source ↗
Lobbying in these areas
Frequently asked
How many EU lobbying meetings has European Confederation of Pharmaceutical Entrepreneurs disclosed?
European Confederation of Pharmaceutical Entrepreneurs (EU Transparency Register no. 87600691525-93) appears in 32 disclosed meetings with EU officials and MEPs between 2024-09-24 and 2026-05-06: 11 with the European Commission and 21 with Members of the European Parliament.
What does European Confederation of Pharmaceutical Entrepreneurs lobby on?
European Confederation of Pharmaceutical Entrepreneurs's disclosed EU meetings most often concern Technology, Health. Every meeting and its topic is listed with its official source on this page.
Who does European Confederation of Pharmaceutical Entrepreneurs meet in Brussels?
Across its disclosed meetings, European Confederation of Pharmaceutical Entrepreneurs has met Commission officials including Maya Matthews, Jana Dabbelt, Katri Teedumäe, and MEPs including SOKOL Tomislav, METZ Tilly, HADJIPANTELA Michalis. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
- EU Transparency Register profile (no. 87600691525-93) ↗
- European Commission meeting disclosures ↗
- European Parliament — MEP meeting declarations ↗
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.